AGM/EGMJul 2, 2026, 04:36 PM
GT Biopharma to Vote on Reverse Stock Split, Share Plan
AI Summary
GT Biopharma, Inc. has filed its definitive proxy statement for its Annual Meeting of Stockholders on August 14, 2026. Key proposals include the election of four directors, ratification of independent accountants, and an advisory vote on executive compensation. Shareholders will also vote on a reverse stock split with a ratio between 1-for-10 and 1-for-30, a simultaneous reduction of authorized shares, and two amendments to the 2022 Omnibus Incentive Plan to increase available shares by 3,500,000 and add an evergreen provision.
Key Highlights
- Stockholders to vote on electing four directors at the Annual Meeting.
- Proposal to ratify Weinberg & Company, P.A. as independent accountants for 2026.
- Advisory vote on executive compensation to be held.
- Proposal for a reverse stock split (1-for-10 to 1-for-30 ratio) and reduction of authorized shares.
- Amendment to 2022 Omnibus Incentive Plan to increase shares by 3,500,000.
- Second amendment to 2022 Plan to adopt an evergreen provision for annual share increases.
- Annual Meeting scheduled for August 14, 2026, with June 30, 2026, as the record date.
- 44,338,573 shares of Common Stock outstanding and entitled to vote as of record date.
Price Impact
More from GTBP